Russia denies capecitabine shortage, cites uninterrupted supplies

Roszdravnadzor officially denies reports of a capecitabine shortage in Russia, asserting uninterrupted supplies. The denial follows earlier claims of drug scarcity, but no independent verification is provided. This matters for oncology patients and pharmaceutical supply chains in Russia.